These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26459237)

  • 21. Statins: An undesirable class of aquatic contaminants?
    Santos MM; Ruivo R; Lopes-Marques M; Torres T; de los Santos CB; Castro LF; Neuparth T
    Aquat Toxicol; 2016 May; 174():1-9. PubMed ID: 26896816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Towards predictive docking at aminergic G-protein coupled receptors.
    Jakubík J; El-Fakahany EE; Doležal V
    J Mol Model; 2015 Nov; 21(11):284. PubMed ID: 26453085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of multiple binding modes of the CDK2 inhibitors, anilinopyrazoles, using the automated docking programs GOLD, FlexX, and LigandFit: an evaluation of performance.
    Sato H; Shewchuk LM; Tang J
    J Chem Inf Model; 2006; 46(6):2552-62. PubMed ID: 17125195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of an automated procedure for the prediction of relative free energies of binding on a set of aldose reductase inhibitors.
    Ferrari AM; Degliesposti G; Sgobba M; Rastelli G
    Bioorg Med Chem; 2007 Dec; 15(24):7865-77. PubMed ID: 17870536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular Docking, Synthesis And Biological Evaluation Of Ergosteryl-Ferulate As A Hmg-Coa Reductase Inhibitor.
    Aziz S; Elfahmi -; Soemardji AA; Sukrasno -
    Pak J Pharm Sci; 2020 May; 33(3):997-1003. PubMed ID: 33191223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postprocessing of docked protein-ligand complexes using implicit solvation models.
    Lindström A; Edvinsson L; Johansson A; Andersson CD; Andersson IE; Raubacher F; Linusson A
    J Chem Inf Model; 2011 Feb; 51(2):267-82. PubMed ID: 21309544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HarmonyDOCK: the structural analysis of poses in protein-ligand docking.
    Plewczynski D; Philips A; Von Grotthuss M; Rychlewski L; Ginalski K
    J Comput Biol; 2014 Mar; 21(3):247-56. PubMed ID: 21091053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crystal structure of archaeal HMG-CoA reductase: insights into structural changes of the C-terminal helix of the class-I enzyme.
    Vögeli B; Shima S; Erb TJ; Wagner T
    FEBS Lett; 2019 Mar; 593(5):543-553. PubMed ID: 30702149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantum Mechanics-Based Fast and Reliable Prediction of Binding Pose Structures.
    Al-Ansi AY; Al-Shawesh GH; Ru X; Lin Z
    J Phys Chem B; 2024 Jun; 128(25):6059-6070. PubMed ID: 38875526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential natural inhibitors of xanthine oxidase and HMG-CoA reductase in cholesterol regulation: in silico analysis.
    Marahatha R; Basnet S; Bhattarai BR; Budhathoki P; Aryal B; Adhikari B; Lamichhane G; Poudel DK; Parajuli N
    BMC Complement Med Ther; 2021 Jan; 21(1):1. PubMed ID: 33386071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aromatic interactions in the binding of ligands to HMGCoA reductase.
    Kee EA; Livengood MC; Carter EE; McKenna M; Cafiero M
    J Phys Chem B; 2009 Nov; 113(44):14810-5. PubMed ID: 19863142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural Inhibitors of HMG-CoA Reductase-An Insilico Approach Through Molecular Docking and Simulation Studies.
    Suganya S; Nandagopal B; Anbarasu A
    J Cell Biochem; 2017 Jan; 118(1):52-57. PubMed ID: 27216569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteopedia entry: HMG-CoA reductase.
    Canner D
    Biochem Mol Biol Educ; 2011; 39(1):64. PubMed ID: 21433257
    [No Abstract]   [Full Text] [Related]  

  • 34. Incorporating backbone flexibility in MedusaDock improves ligand-binding pose prediction in the CSAR2011 docking benchmark.
    Ding F; Dokholyan NV
    J Chem Inf Model; 2013 Aug; 53(8):1871-9. PubMed ID: 23237273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Machine learning in computational docking.
    Khamis MA; Gomaa W; Ahmed WF
    Artif Intell Med; 2015 Mar; 63(3):135-52. PubMed ID: 25724101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DrugScore(CSD)-knowledge-based scoring function derived from small molecule crystal data with superior recognition rate of near-native ligand poses and better affinity prediction.
    Velec HF; Gohlke H; Klebe G
    J Med Chem; 2005 Oct; 48(20):6296-303. PubMed ID: 16190756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-based design and screen of novel inhibitors for class II 3-hydroxy-3-methylglutaryl coenzyme A reductase from Streptococcus pneumoniae.
    Li D; Gui J; Li Y; Feng L; Han X; Sun Y; Sun T; Chen Z; Cao Y; Zhang Y; Zhou L; Hu X; Ren Y; Wan J
    J Chem Inf Model; 2012 Jul; 52(7):1833-41. PubMed ID: 22725250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pose prediction approach based on ligand 3D shape similarity.
    Kumar A; Zhang KY
    J Comput Aided Mol Des; 2016 Jun; 30(6):457-69. PubMed ID: 27379501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Testing inhomogeneous solvation theory in structure-based ligand discovery.
    Balius TE; Fischer M; Stein RM; Adler TB; Nguyen CN; Cruz A; Gilson MK; Kurtzman T; Shoichet BK
    Proc Natl Acad Sci U S A; 2017 Aug; 114(33):E6839-E6846. PubMed ID: 28760952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statins in therapy: understanding their hydrophilicity, lipophilicity, binding to 3-hydroxy-3-methylglutaryl-CoA reductase, ability to cross the blood brain barrier and metabolic stability based on electrostatic molecular orbital studies.
    Fong CW
    Eur J Med Chem; 2014 Oct; 85():661-74. PubMed ID: 25128668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.